Max Healthcare Institute Ltd (IN:MAXHEALTH)
:MAXHEALTH
Want to see IN:MAXHEALTH full AI Analyst Report?
Top Page
Max Healthcare Institute Ltd
(MAXHEALTH)
Select Model
Select Model
Rating:61Neutral
Price Target:
₹1,152.00
▼(-4.19% Downside)
Action:Reiterated
Date:05/22/26
The score is driven primarily by solid underlying financial performance (growth and operating profitability), but it is held back by weaker/volatile free cash flow and a recent step-up in debt. Technicals are supportive but look overbought, and valuation is a key headwind due to the high P/E and minimal yield.
Positive Factors
Revenue Growth
Sustained multi-year revenue expansion indicates durable demand for hospital services and successful scaling of capacity and specialties. A growing top line supports reinvestment in facilities and talent, and reduces per-unit overhead, strengthening long-term competitive position and market share.
Negative Factors
Recent Sharp Debt Increase
A step-up in leverage elevates interest expense sensitivity and constrains strategic optionality. Higher debt increases refinancing and liquidity risk if rates rise or cash generation weakens, potentially limiting ability to pursue expansions or absorb operational shocks over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained multi-year revenue expansion indicates durable demand for hospital services and successful scaling of capacity and specialties. A growing top line supports reinvestment in facilities and talent, and reduces per-unit overhead, strengthening long-term competitive position and market share.
Read all positive factors
Max Healthcare Institute Ltd (MAXHEALTH) vs. iShares MSCI India ETF (INDA)
Market Cap
₹938.45B
Dividend Yield0.14%
Average Volume (3M)80.22K
Price to Earnings (P/E)65.0
Beta (1Y)1.19
Revenue Growth19.14%
EPS Growth34.04%
CountryIN
Employees19,500
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)13.96
Shares Outstanding973,243,800
10 Day Avg. Volume58,776
30 Day Avg. Volume80,220
Financial Highlights & Ratios
PEG Ratio1.90
Price to Book (P/B)8.67
Price to Sales (P/S)11.13
P/FCF Ratio626.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)19.95
Revenue Forecast (FY)₹122.08B
Max Healthcare Institute Ltd Business Overview & Revenue Model
Company Description
Max Healthcare Institute Limited provides healthcare services in India. It offers services in various specialties, including cancer care/oncology, cardiac sciences, neuro sciences, liver transplant and biliary sciences, orthopaedics, nephrology, k...
How the Company Makes Money
Max Healthcare primarily makes money by delivering healthcare services to patients through its hospitals and associated centers. Its core revenue stream is patient care services, which typically include (i) inpatient services (room/bed charges, in...
Max Healthcare Institute Ltd Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
70
Positive
Cash Flow
52
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.41B | 83.73B | 70.28B | 54.06B | 45.63B | 39.37B |
| Gross Profit | 52.71B | 65.83B | 43.77B | 33.53B | 28.31B | 21.89B |
| EBITDA | 20.81B | 23.57B | 18.31B | 14.82B | 12.23B | 9.47B |
| Net Income | 13.57B | 14.42B | 10.76B | 10.58B | 11.04B | 6.05B |
Balance Sheet | ||||||
| Total Assets | 162.81B | 172.31B | 152.14B | 120.00B | 101.02B | 91.89B |
| Cash, Cash Equivalents and Short-Term Investments | 5.73B | 7.71B | 6.82B | 9.80B | 13.74B | 4.81B |
| Total Debt | 32.75B | 34.78B | 30.10B | 13.05B | 6.89B | 11.33B |
| Total Liabilities | 62.29B | 64.84B | 58.34B | 35.92B | 26.92B | 29.07B |
| Stockholders Equity | 100.52B | 107.47B | 93.81B | 84.08B | 74.10B | 62.82B |
Cash Flow | ||||||
| Free Cash Flow | -413.10M | 1.49B | 4.94B | 3.36B | 8.74B | 1.87B |
| Operating Cash Flow | 8.18B | 16.33B | 14.59B | 11.22B | 12.09B | 7.48B |
| Investing Cash Flow | -9.66B | -16.89B | -16.32B | -12.85B | -11.87B | -7.72B |
| Financing Cash Flow | -353.20M | 592.70M | -1.64B | -2.64B | -2.89B | -2.94B |
Max Healthcare Institute Ltd Technical Analysis
Negative
1202.35
Price Trends
996.01
Negative
1016.52
Negative
1084.62
Negative
Market Momentum
-0.65
Positive
36.72
Neutral
7.34
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MAXHEALTH, the sentiment is Negative. The current price of 1202.35 is above the 20-day moving average (MA) of 1024.98, above the 50-day MA of 996.01, and above the 200-day MA of 1084.62, indicating a bearish trend. The MACD of -0.65 indicates Positive momentum. The RSI at 36.72 is Neutral, neither overbought nor oversold. The STOCH value of 7.34 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MAXHEALTH.
Max Healthcare Institute Ltd Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ₹1.18T | 60.54 | ― | 0.27% | 15.76% | 34.29% | |
67 Neutral | ₹702.04B | 67.31 | ― | 0.11% | 17.28% | 34.55% | |
66 Neutral | ₹318.00B | 57.40 | ― | 0.04% | 19.44% | 15.55% | |
64 Neutral | ₹388.07B | 47.76 | ― | 0.24% | 41.43% | 2.10% | |
63 Neutral | ₹377.22B | 96.70 | ― | 0.84% | 12.20% | -93.03% | |
61 Neutral | ₹938.45B | 65.05 | ― | 0.14% | 19.14% | 34.04% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
IN:MAXHEALTH
Max Healthcare Institute Ltd
964.25
-184.82
-16.08%
IN:APOLLOHOSP
Apollo Hospitals Enterprise Limited
8,177.95
1,282.80
18.60%
IN:ASTERDM
Aster DM Healthcare Ltd.
728.05
175.67
31.80%
IN:FORTIS
Fortis Healthcare Ltd.
929.90
208.65
28.93%
IN:MEDANTA
Global Health Limited
1,182.80
-31.16
-2.57%
IN:NH
Narayana Hrudayalaya Ltd.
1,898.95
156.30
8.97%
Max Healthcare Institute Ltd Corporate Events
Max Healthcare clears FY26 results, dividend and major expansion in Lucknow
May 21, 2026
Max Healthcare Institute Ltd has approved audited standalone and consolidated financial results for the fourth quarter and full year ended March 31, 2026, and recommended a final dividend of ₹2 per share for FY 2025-26, subject to shareholde...
Max Healthcare Wins Full Withdrawal of ₹55.20 Crore GST Demand
Apr 21, 2026
Max Healthcare Institute Ltd has disclosed that the Delhi GST authority has issued a rectification order in its favour related to an earlier tax dispute over alleged excess availment of input tax credit. The order fully withdraws the previously ra...
Max Healthcare launches e-voting postal ballot for director re-appointment
Apr 12, 2026
Max Healthcare Institute Ltd has notified stock exchanges that it has published a postal ballot notice in national and regional newspapers and has completed dispatch of the notice to eligible shareholders via email. The move underscores the compan...
Max Healthcare reports no demat requests, confirms fully dematerialized share base
Apr 7, 2026
Max Healthcare Institute Ltd has disclosed that its registrar and share transfer agent, MUFG Intime India Private Limited, confirmed there were no requests for dematerialization of shares during the quarter ended March 31, 2026. The company also r...
Max Healthcare Closes Trading Window Ahead of FY26 Results
Mar 26, 2026
Max Healthcare Institute Ltd has announced the closure of its trading window for all designated persons and their immediate relatives from April 1, 2026, until 48 hours after the declaration of its financial results for the fourth quarter and full...
Max Healthcare Subsidiary ET Planners Dissolved After Voluntary Liquidation
Mar 25, 2026
Max Healthcare Institute Ltd has disclosed that its step-down wholly owned subsidiary, ET Planners Private Limited, has been dissolved following an order by the National Company Law Tribunal’s New Delhi Bench under the voluntary liquidation ...
Max Healthcare to Engage Investors at J.P. Morgan India Forum 2026 in Singapore
Mar 2, 2026
Max Healthcare Institute Ltd has announced that its Chairman and Managing Director will participate in the J. P. Morgan India Forum 2026, an investor conference to be held physically at the Fullerton Hotel in Singapore on March 9 and 10, 2026. The...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.